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Background and Purpose: Post-traumatic cardiac dysfunction often occurs in
multiply injured patients (ISS ≥ 16). Next to direct cardiac injury, post-traumatic cardiac
dysfunction is mostly induced by the release of inflammatory biomarkers. One of these is
the heparin-binding factor Midkine, which is elevated in humans after fracture, burn injury
and traumatic spinal cord injury. Midkine is associated with cardiac pathologies but the
exact role of Midkine in the development of those diseases is ambiguous. The systemic
profile of Midkine after multiple trauma, its effects on cardiomyocytes and the association
with post-traumatic cardiac dysfunction, remain unknown.
Experimental Approach: Midkine levels were investigated in blood plasma of multiply
injured humans and pigs. Furthermore, human cardiomyocytes (iPS) were cultured
in presence/absence of Midkine and analyzed regarding viability, apoptosis, calcium
handling, metabolic alterations, and oxidative stress. Finally, the Midkine filtration capacity
of the therapeutic blood absorption column CytoSorb ®300 was tested with recombinant
Midkine or plasma from multiply injured patients.
Key Results: Midkine levels were significantly increased in blood plasma of multiply
injured humans and pigs. Midkine acts on human cardiomyocytes, altering their
mitochondrial respiration and calcium handling in vitro. CytoSorb®300 filtration reduced
Midkine concentration ex vivo and in vitro depending on the dosage.
Conclusion and Implications: Midkine is elevated in human and porcine plasma after
multiple trauma, affecting the functionality and metabolism of human cardiomyocytes
in vitro. Further examinations are required to determine whether the application of
CytoSorb®300 filtration in patients after multiple trauma is a promising therapeutic
approach to prevent post-traumatic cardiac disfunction.
Keywords: polytrauma, cardiac dysfunction, fracture treatment, damage associated molecular pattern, toll-like
receptor, toll-like receptor signaling, prevention cardiac injury, CytoSorb® 300
Lackner et al. Midkine After Multiple Trauma
INTRODUCTION
According to the World Health Organization (WHO), trauma
accounts for 10% of deaths and 16% of disabilities worldwide (1).
Multiple trauma in humans (Injury Severity Score, ISS ≥ 16)
are characterized by a massive release of different inflammatory
biomarkers, such as cytokines, and damage associated molecular
patterns (DAMPs). This damage affects different organs of the
body and can trigger whole-body inflammation after trauma
(2, 3). A substantial release of these trauma-dependent molecules
is associated with the development of the so-called systemic
inflammatory response syndrome (SIRS) and the multiple organ
dysfunction syndrome (MODS), which are both associated with
an increased mortality (4, 5). Many of the released inflammatory
cytokines and DAMPs were recently shown to be cardio-
depressive by acting on cardiomyocytes (CMs), altering their
calcium handling, redox balance, signaling transduction, and
finally resulting in post-traumatic cardiac dysfunction (6, 7).
One inflammatory cytokine is the heparin-binding growth- and
differentiation factor Midkine (Mdk). Increased Mdk expression
is associated with different traumatic conditions such as bone
fracture, burn injury, traumatic spinal cord injury, and sepsis
(8–11). Increased Mdk in human blood can persist for overall
42 days after fracture (11). Furthermore, Mdk impairs fracture
healing by reducing bone formation and increasing neutrophil
infiltration during the fracture healing process (12, 13). However,
the trauma-dependent elevation of Mdk in multiply injured
patients as well as the exact impact of Mdk on the heart after
trauma remains unclear. In patients with chronic heart failure,
circulating Mdk increases significantly and is regarded as a novel
marker, predicting different cardiac events (14, 15). Moreover,
Mdk plays a role in ischemic heart injury, myocardial infarction
and cardiac hypertrophy (16–18). Nevertheless, the function
of Mdk in these different pathologies is still controversial,
because in some cases such as ischemic heart injury, chronic
heart failure and myocardial infarct, Mdk has positive effects
by improving cell survival and cardiac function, inducing
angiogenesis and reducing detrimental remodeling (17, 19,
20). In contrast, Mdk reduces cellular survival and induces
pathological remodeling as well as fibrosis in patients with
cardiac hypertrophy (18). Consequently, the exact effect of
Mdk on the heart is ambiguous since Mdk can have beneficial
and detrimental effects in cardiac pathology. The function of
Mdk as an inflammatory cytokine on the heart during trauma
especially requires clarification. After all, Mdk might be a
potential therapeutic option in cardiac diseases as well as in
the treatment and prevention of post-traumatic cardiac injury
(21, 22). Mdk has been shown to play an important role in
active myocarditis in patients and in experimental autoimmune
myocarditis in mice (23). In these instances, Mdk promotes the
recruitment of polymorphonuclear neutrophils (PMNs) and the
production of neutrophil extracellular traps (NETs) in cardiac
tissues, resulting in impaired systolic function (23). Increased
activation and recruitment of neutrophils in cardiac tissue were
also observed in humans after trauma and in experimental blunt
chest trauma models in rats. In addition, it is linked to increased
systemic levels of extracellular histones by NETosis, leading to
cardiac dysfunction (24, 25).
In this study, we investigate the Mdk elevation in blood
circulation after multiple trauma in pigs and humans. We
further aim to thoroughly examine the effects of Mdk on human
CMs. With regards to therapeutic options for posttraumatic
cardiac dysfunction, the study aims to investigate the usage of
CytoSorb R© 300 hemadsorption. In clinical settings, CytoSorb R©
300 hemadsorption improved the outcome of patients with
endotoxemia, necrotizing fasciitis, septic shock, and cardiac
surgery (26–29). Furthermore, CytoSorb R© hemadsorption
resulted in immediate hemodynamic stabilization and increased
survival rates in patients with multiple organ failure (30).
CytoSorb R© 300 consists of highly porous (styrene-co-
divinylbenzene) hemadsorbent polymer beads, which can
remove substances within 10–60 kDa of molecular weight,
such as complement factor 5a, cytokines DAMPs and pathogen
associated molecular patterns (PAMPs), from circulating
blood (26, 31). Similarly, the high-mobility group box 1
protein (HMGB1) can be removed from blood in a time
dependent manner (31). Lastly, the study examines the
capacity of CytoSorb R© 300 to filtrate Mdk, which may be
used as a therapeutic approach for preventing and handling
post-traumatic cardiac dysfunction.
MATERIALS AND METHODS
Human Blood Samples
Human plasma from 11 multiply injured patients with a
history of acute blunt or penetrating trauma and an ISS ≥
16 was collected after hospital admission in the University
Hospital of the Goethe-University Frankfurt with institutional
ethics committee approval (312/10), in accordance with the
Declaration of Helsinki and following the Strengthening the
Reporting of Observational studies in Epidemiology (STROBE)-
guidelines (32). All enrolled patients either signed the written
informed consent form or written informed consent was
obtained from the nominated legally authorized representative
of the participants in accordance with ethical standards.
Exclusion criteria were the patients being younger than 18
or older than 80 years, presenting severe burn injury, acute
myocardial stroke, cancer or chemotherapy, immunosuppressive
drug therapy, HIV, infectious Hepatitis, acute CMV infection,
and/or thromboembolic events. Control blood samples were
collected from healthy volunteers (n = 6, 50:50 female male, no
comorbidities). Randomization of the groups was not possible
during the sample collection. Blood samples were withdrawn
in ethylenediaminetetraacetic acid (EDTA) tubes (Sarstedt,
Nürmbrecht, Germany) directly after admission. The samples
were kept on ice until centrifugation at 2,100 g for 15min. Then,
the supernatant was collected and stored at−80◦C until assay.
Animals
This study presents partial results obtained from a large animal
porcine multiple trauma model, conducted by the TREAT
research group.
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The animal housing and experimental protocols were
approved by the Cantonal Veterinary Department, Zurich,
Switzerland, under license no. ZH 138/2017, and were in
accordance with Swiss Animal Protection Law. Housing and
experimental procedures also conformed to the European
Directive 2010/63/EU of the European Parliament and of the
Council on the Protection of vertebrate animals used for
scientific purposes (Council of Europe no. 123, Strasbourg
1985) and to the Guide for the Care and Use of Laboratory
Animals (Institute of Laboratory Animal Resources, National
Research Council, National Academy of Sciences, 2011). Twenty-
five male pigs weighting 50 ± 5 kg (Sus scrofa domestica)
were included in the study (mean height, snout-tail length:
123,6 cm). Animals were held in a controlled environment with
21 ± 3◦C room temperature (50% humidity), with a light/dark
cycle of 12 h. Water was available for animals ad libitum.
General instrumentation, anesthesia and trauma induction were
described previously by Horst et al. (33).
Analgesia and Anesthesia
For premedication, pigs received an intramuscular injection
with ketamine (20 mg/kg body weight), azaperone (1–2
mg/kg body weight) and atropine (0.1–0.2 mg/kg body
weight). Anesthesia was performed by intravenous application
of propofol (2,6-diisopropylphenol) (1–2 mg/kg body
weight). Anesthesia was maintained during the study
period with propofol (5–10 mg/kg/h). Pain medication was
ensured by sufentanyl (1 µg/kg/h) perfusion over the whole
observation period.
Multiple Trauma in Pigs
Analgesia and Anesthesia of the animals was maintained during
the whole procedure.
Pigs underwent either multiple trauma (n = 20) or sham-
procedure (n = 5). Multiple trauma includes a combination
of a penetrating thorax trauma, laparotomy, liver laceration,
femur fracture, and hemorrhagic shock (ISS ≥ 27). Control
animals underwent sham-procedure (n = 5). Femur fracture
was induced by a bolt gun (Blitz-Kernen, turbocut JOBB
GmbH, Germany), positioned on the mid third of the left
femur. The gun was loaded with cattle-killing cartridges (9 x
17; DynamitNobel AG, Troisdorf, Germany). For introduction
of blunt chest trauma, a pair of panels (steel 0.8 cm, lead
1.0 cm thickness) was placed on the right dorsal lower chest. A
shock wave was induced by a bolt shot (Blitz-Kerner, turbocut
JOBB GmbH, Germany), which was applied onto the panel
using cattle-killing cartridges as previously described (34, 35).
Midline-laparotomy was performed by exploring the right upper
liver lobe. Penetrating hepatic injury was induced by cross-like
incision halfway through the liver tissue. After a short period
of uncontrolled bleeding (30 s), liver package was performed.
Directly after the hepatic package, pressure-controlled and
volume-limited hemorrhagic shock was induced by withdrawing
blood until a mean arterial pressure (MAP) of 30 ± 5mm Hg
was reached. Maximal withdrawal amounts to 45% of total blood
volume. The reached MAP was maintained for 60min. At the
end of the shock period, animals were resuscitated according to
established trauma guidelines (ATLS R©, AWMF-S3 guideline on
Treatment of Patients with Severe and Multiple Injuries R©) by
adjusting FiO2 and an initial substitution of the withdrawn blood
volume with Ringerfundin, fluid maintenance was performed
by continuous infusing additional fluids (Ringerfundin, 2
ml/kg body weight/h). Moreover, pigs were rewarmed until
normothermia (38.7–39.8◦C) was reached. Sham procedure (n
= 5) included instrumentation and anesthesia but without
trauma or hemorrhage. The multiple trauma group (n = 20)
was randomized in four therapy arms: pigs received either
femoral nailing without reaming (n = 5), standard reaming
(n = 5), reamed irrigation and aspiration (RIA I) (n = 5)
or reamed irrigation and aspiration with reduced diameter
and improved control of irrigation and suction (RIA II)
(n = 5). In all groups a shortened conventional tibia nail
was introduced.
Follow-Up and Euthanasia
Hemodynamic parameters were continuously monitored for
6 h. Pigs were euthanized under deep general anesthesia with
intravenous Na-Pentobarbital.
This animal model represents a clinically relevant porcine
model of severe multiple trauma (pulmonary contusion,
extremity injury, liver laceration) with post-traumatic
observation period under ICU conditions (33).
Sample Collection
Serum and plasma samples were collected at baseline, 4 and
6 h after multiple trauma and kept on ice. After centrifugation
(1,500 g for 12min at 4◦C), serum and EDTA-plasma were
removed and stored at−80◦C until analysis. Heart tissue samples
were obtained 6 h after resuscitation. Tissue of the superficial and
the luminal left ventricle was fixed with 4% formalin, followed by
embedding in paraffin. Furthermore, tissue was quick-frozen in
liquid nitrogen, followed by storage at−80◦C until analysis.
Midkine ELISA
For determination of Midkine in human and porcine plasma,
as well as for the CytoSorb R© 300 experiments, the human
Midkine ELISA (R&D Systems, McKinley, MN, USA) was used.
All procedures were performed according to manufacturers’
instructions. Midkine ELISA was performed by a blinded
investigator. Human plasma samples were diluted 1:4 and
porcine plasma samples were diluted 1:2.
ips-Cardiomyocyte Cell Culture
Human cardiomyocytes (iPS) (Cellular Dynamics, Madison,
WI, USA) were cultured for 10 days in maintenance medium
at 37◦C and in an atmosphere of 7% CO2, according to
manufacturers’ recommendations.
Binding Analysis of FITC-Labeled Midkine
Fluorescein isothiocyanate (FITC) (Sigma Aldrich, St. Louis,
MO, USA) was dissolved in DMSO. Two mg/ml Midkine
(Dianova, Hamburg, Germany), dissolved in 0.1M NaHCO3
were added to 3 mg/ml fluorescein isothiocyanate (FITC) (Sigma
Aldrich, St. Louis, MO, USA) solution and were incubated for 1 h
at RT while continuously shaking. Unbound FITC was removed
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by using SnakeSkin R© dialysis tube (ThermoScientific, Waltham,
MA, USA). For dialysis, 1X phosphate buffered saline was used.
Human CMs were seeded at a density of 6.3 × 104 cells/cm2
on ibidi 12-well chamber slides (ibidi, Germany). Afterwards,
cells were incubated for 30 and 60min with 100 ng/ml FITC-
labeled Midkine. Cells were washed, fixed with 4% formalin and
cell nuclei were counterstained using Hoechst (Sigma Aldrich,
St. Louis, MO, USA). Cells were mounted with ProLong R© Gold
Antifade Mountant (ThermoScientific, Waltham, MA, USA).
Cells were analyzed by blinded investigator by using Axio Imager
M.2 microscope (Zeiss, Jena, Germany) and the Zeiss ZEN 2.3
software (Zeiss, Jena, Germany). Images were performed with
40x magnification (N.A. 0.75).
Cell Viability Assay
Cell viability was analyzed using Cell Titer-Glo R© Luminescent
Cell Viability Assay (Promega, Madison, WI, USA). Cells were
seeded with a density of 6.3× 104 cells/cm2 on a 96-well plate and
treated with differentMidkine concentrations (0.05, 0.1, 1µg/ml)
for 3 h, or with 1µg/ml for different incubation times (0.5, 1, or
3 h). All procedures were performed according to manufacturers’
instructions. For all experiments n= 6.
Troponin I ELISA
Human CMs were seeded with a density of 6.3 × 104 cells/cm2
on a 24-well plate and treated for 6 h with 100 ng/ml Midkine
at 37◦C and 7% CO2. Supernatant was collected and troponin
I in supernatant was determined by using Human Cardiac
Troponin I ELISA (Abcam, Cambridge, UK). All procedures
were performed according to manufacturers’ instructions. For all
experiments n= 6.
Caspase-3/7 Assay
Human cardiomyocytes were seeded with a density of 6.3 × 104
cells/cm2 on a 96-well plate and treated with 100 ng/ml Midkine
for 6 h at 37◦C. Caspase-3/7 activity in human cardiomyocytes
was examined by using Caspase-Glo R© 3/7 Assay (Promega,
Madison, WI, USA). All procedures were performed according
to manufacturers’ instructions. For all experiments n= 6.
Live Cell Imaging
Live cell imaging was performed using Leica Microscope SP8
and LAS X software (Leica, Wetzlar, Germany). Cells were
seeded with a density of 6.3 × 104 cells/cm2 on a 96-well plate
and were pre-loaded with 5µM calcium indicator Fluo-3AM
(Life Technologies, Carlsbad, CA, USA) and were incubated for
30min at 37◦C and 7% CO2. After incubation with Fluo-3AM,
cells were analyzed immediately. For measurements, cells were
placed in special live cell imaging chamber, adjusted at 37◦C and
7% CO2. Cells were incubated with 100 ng/ml Mdk for 30min
and calcium signals were recorded and evaluated by using LAS
X software. Cell culture medium was used during measurements.
Live cell imaging was performed with 63x magnification (N.A.
1.2, water). Calcium peaks were determined and compared to
baseline values. For all experiments n= 6.
Calcium Measurements
For calcium measurements, human cardiomyocytes (iPS) were
seeded with a density of 6.3 × 104 cells/cm2 on ibidi 8-
well chambers (ibidi, Germany). Before the measurements,
cells were incubated with 100 ng/ml Midkine 60min before
the start of the experiments, as well as for the duration of
the experiment. For measurement of changes in intracellular
Ca2+ concentration, cells were loaded with 5µM Fura-2
(ThermoScientific, Waltham, MA, USA) for 30min (in presence
of pharmacological compounds if needed). After incubation, cells
were washed twice with bath solution (in mM: 140 NaCl; 5.4 KCl;
MgCl2; 1.8 CaCl2; 5.5 Glucose; 5 Hepes; pH= 7.4). Fluorescence
imaging was performed on a Cell Observer inverse microscope
(Zeiss, Jena, Germany). Cells were illuminated for 90min at a rate
of 2Hz at each excitation wavelength (340 and 380 nm). Images
were acquired using MetaFluor (Molecular Devices, Ismaning,
Germany). Cells were measured in bath solution using 40x
magnification (N.A. 1.3) at room temperature. Fura-2 ratios were
calculated with ImageJ and the data obtained were analyzed with
the Matlab script PeakCaller (36). For all experiments n= 6.
RNA Isolation
For qPCR experiments, human CMs were seeded at a
density of 6.3 × 104 cells/cm2 on a 24-well plate and
were treated with 100 ng/ml Midkine for 6 h at 37◦C and
7% CO2. Cells were lysed with RLY lysis buffer (Meridian
Bioscience, Cincinnati, OH, USA), containing 10 µl/ml β-
mercaptoethanol (Sigma Aldrich, St. Louis, MO, USA). RNA
isolation from cell lysates was performed by using ISOLATE
II RNA Mini Kit (Meridian Bioscience, Cincinnati, OH, USA).
Remaining DNA was digested by DNase I (Meridian Bioscience,
Cincinnati, OH, USA) for 15min at RT as recommended by
the manufacturer.
Reverse Transcribed Quantitative
Polymerase Chain Reaction (RT-qPCR)
The respective RNA samples were reverse transcribed in cDNA
using SuperScript R© IV VILO R© MasterMix (Life Technologies,
Carlsbad, CA, USA). For cDNA transcription, 1–5 ng/ml
mRNA were used, and experiment was performed according
to manufacturer’s instructions. For quantitative PCR, the
PowerUp R© SYBR R© Green Master Mix (Applied Biosystems,
Waltham, MA, USA) was used. All procedures were performed
according to the manufacturers’ instructions. For qPCR, the
QuantStudio3 (Applied Biosystems, Waltham, MA, USA) system
was utilized. Five-hundred to seven-hundred ng/ml cDNA were
used for quantitative PCR. Quantitative mRNA expression of
human troponin I (for: 5′-CCTCCAACTACCGCGCGCTTAT-3′,
rev: 5′-CTGCAATTTTCTCGAGGCGG-3′), sarco/endoplasmic
reticulum Ca2+-ATPase (SERCA2a) (for: 5′-CTCCTTGCCCGT
GATTCTCA-3′, rev: 5′-CCAGTATTGCAGGTTCCAGGT-
3′), ryanodine receptor 1 (RyR1) (for: 5′-GGGTTCCTGCCC
GACATGAG-3′, rev: 5′-GCACAGGTAGCGGTTCACG-3′),
Na+/Ca2+ exchanger (NCX) (for: 5′-GCCTGGTGGAGATGAG
TGAG-3′, rev: 5′-ACAGGTTGGCCAAACAGGTA-3′), toll-like
receptor 4 (TLR4) (for: 5′-CCTGCGTGGAGGTGTGAAAT-3′,
rev: 5′-CTGGATGGGGTTTCCTGTCAA-3′), toll-like receptor
9 (TLR9) (for: 5′-AGACCTGAGGGTGGAAGTGT-3′, rev:
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FIGURE 1 | Midkine levels in blood plasma of multiply injured humans and
pigs. Midkine levels (pg/ml) in shock room blood plasma from multiply injured
patients compared to healthy control group (n = 10) (A). Midkine levels (pg/ml)
in blood plasma of multiply injured pigs (B). The pigs’ femur fracture was either
treated with femoral nailing (nailing, n = 5), conventional (conv, n = 5), or with
reamer irrigator aspirator 1 or 2 (RIA I or RIA II, each n = 5). Control animals
received sham-procedure (n = 5). Evaluation of blood plasma at baseline (BL)
and 6 h after trauma. Results are presented as mean ± SEM. Data were
analyzed by one-way ANOVA followed by Dunnett’s or Tukey’s multiple
comparison test. Results are significant *p < 0.05.
5′-CTGGATAGCACCAGTAGCGG-3′) and purigenic receptor
subtype 7 (P2X7) (for: 5′-CACACCAAGGTGAAGGGGAT-3′,
rev: 5′-GGTGTAGTCTGCGGTGTCAA-3′) was examined and
calculated by the cycle threshold method 11Ct. Respective
genes were normalized to expression of the housekeeping gene
glutaraldehyde-phosphate dehydrogenase (GAPDH) (forward:
5′-TCTCTGCTCCTCCTGTTCGAC-3′, reverse: 5′-CCAA
TACGACCAAATCCGTTGA-3′) in order to exclude variations.
Quantitative mRNA expression was determined by the double-
threshold method (11CT). Results are presented as mean fold
change. For all experiments n= 6.
Reactive Oxygen Species (ROS)
For analysis of cellular ROS, human CMs were seeded at a
density of 6.3 × 104 cells/cm2 on ibidi 12-well slides (ibidi,
Germany). HumanCMswere treated with 100 ng/mlMidkine for
6 h at 37◦C and 7% CO2. After treatment, cells were incubated
for another 30min with 5µM CellROX R© Deep Red Reagent
(Life Technologies, Carlsbad, CA, USA) at 37◦C and 7% CO2.
Afterwards, cells were fixed with 4% formaldehyde and cell
nuclei were stained with Hoechst. Cell were mounted with
ProLong R© Gold Antifade Mountant. Cells were investigated
by blinded investigator by fluorescence microscopy using Axio
Imager M.2 microscope and the Zeiss ZEN 2.3 software.
Imaging was performed by using 20x magnification (N.A. 0.5).
Relative amount of reactive oxygen species was determined by
Zeiss ZEN 2.3 software in order to exclude variations. For all
experiments n= 6.
Mitochondrial Respiration With Seahorse
XF Analyzer
Mitochondrial respiration was analyzed by using the Seahorse
XFe96 Analyzer (Agilent Technologies, Santa Clara, CA, USA).
This extracellular flux analyzer makes it possible to perform
highly accurate real-time measurements of cellular metabolism
in living cells by simultaneously quantifying the rates of
extracellular acidification (ECAR) and oxygen consumption
(OCR), and measuring the glycolysis and the mitochondrial
respiration of the cells. For the analysis of mitochondrial
respiration, the Seahorse XF Cell Mito Stress Test Kit (Agilent
Technologies, Santa Clara, CA, USA) was used. The Seahorse
XF Cell Mito Stress Test Kit is an optimized solution for
assessing mitochondrial function. During the experiment, the
ECAR and the OCR were continuously measured, gaining
the parameter for the basal (baseline) respiration of the
mitochondria. Afterwards, 2µM oligomycin, 1µM carbonyl
cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), and
0.5µM antimycin A and rotenone were pneumatically injected
into the media of the cells. After automatically and gently
mixing, the OCR and the ECAR were measured at multiple
times after each injection. After the experiment, cells were
fixed with 4% formalin at 4◦C overnight. Then, cells were
stained with 0.3% Janus-Green solution (Sigma Aldrich, St.
Louis, MO, USA), washed and resolved with 0.5M hydrochloric
acid. Optical density was measured at 630 nm and OCR values
were normalized to OD 630 nm values to exclude variations.
Results were evaluated using Seahorse Wave 2.4 software
(Agilent Technologies, Santa Clara, CA, USA), gaining the
parameter for spare respiratory capacity of the mitochondria.
For the analysis of mitochondrial respiration, cells were seeded
with a density of 5 × 105 cells/cm2 on Seahorse XFe96
analyzer cell culture plates (Agilent Technologies, Santa Clara,
CA, USA) and incubated for 6 h with 100 ng/ml Midkine
and the above- mentioned procedure was performed. For all
experiments n= 6.
CytoSorb® 300 Experiments
For the therapeutic experiments, the CytoSorb R© 300 was used
(CytosorbensInc., MonmouthJunction, NJ, USA). Therefore,
small columns were prepared. An excess of CytoSorb R© 300 at the
ratio 2:1 (CytoSorb R© 300 to plasma samples) was added on the
column as recommended by the manufacturers. Human shock
room blood plasma samples were added on the columns and were
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FIGURE 2 | Effects of Midkine on human cardiomyocytes. Immunofluorescence staining of human cardiomyocytes (A). Human cardiomyocytes were treated for 30
and 60min with 100 ng/ml fluorescein isothiocyanate (FITC)-labeled Midkine (green). Cell nuclei were counterstained with Hoechst (blue). Cell viability of human
cardiomyocytes (Luminescence in counts/sec) treated for 0.5, 1, and 3 h with 100 ng/ml Midkine (B). Cell viability of human cardiomyocytes (Luminescence in
counts/sec) treated for 3 h with 0.05, 0.1, and 1µg/ml Midkine (C). Troponin I (ng/ml) in supernatant of human cardiomyocytes, treated for 6 h with 100 ng/ml Midkine
(D). Results are presented as mean ± SEM. For all experiments n = 6. Data were analyzed by two-tailed, unpaired students t-test.
incubated for 6 or 3 h at RTwhile continuously shaking. For time-
doses experiments, different Midkine concentrations (10,000,
5,000, 2,500, 2,000, 1,500, 1,000, 500, 1,000 pg/ml) diluted in
PBS with 1% BSA were added on the columns and were also
incubated for 6 and 3 h at RT, while continuously shaking. For
all experiments n= 6.
Statistical Analysis
All values were expressed as means ± SEM. Data were
analyzed by one-way ANOVA followed by Dunnett’s or Tukey’s
multiple comparison test. For the statistical analysis of two
groups, unpaired two-tailed students t-test was used. p ≤ 0.05
was considered statistically significant. GraphPad Prism 7.0
software was used for statistical analysis (GraphPad Software,
Incorporated, San Diego, CA, USA).
RESULTS
Midkine Plasma Levels in Multiply Injured
Humans and Pigs
In humans as well as in pigs, the blood plasma concentrations
of Midkine increased after multiple trauma compared to
the healthy controls (Figures 1A,B). Animals submitted to
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FIGURE 3 | Calcium handling of human cardiomyocytes. Delta calcium peaks (msec) of human cardiomyocytes treated for 30min with 100 ng/ml Midkine (A).
Frequency of calcium signals (sec) of human cardiomyocytes treated for 60min with 100 ng/ml Midkine (B). Traces of calcium signals of human cardiomyocytes (Mean
Calcium peaks of ration of interest (ROI) vs. time in sec) (C,D). Traces of calcium signals of human cardiomyocytes (Ratio of Fura-2 signals in A.U. vs. time in sec)
(E,F). Different colors for selected ROI of calcium signals of the cells. For all experiments n = 6. Results are presented as mean ± SEM. Data were analyzed by
one-way ANOVA followed by Dunnett’s or Tukey’s multiple comparison test. Results are significant *p < 0.05.
reamed femoral nailing showed significantly higher Mdk levels
when compared with pigs treated with conventional femoral
nailing or with reamer irrigator aspirator treatment (RIA I/II;
Figure 1B). This indicates that Mdk levels correlate with the
invasiveness of the reaming method. In multiply injured pigs,
plasma Mdk levels increased significantly after 6 h in the group
with conventional reaming of the fracture compared to the
control group.
Since plasma Mdk levels increased after multiple
trauma, we investigated whether Mdk affects human
cardiomyocytes (CMs). After 30 and 60min the Mdk
was actively absorbed into the human CMs and
was primarily located around their nucleus in vitro
(Figure 2A).
Cell Viability, Cell Damage, and Calcium
Handling of Human Cardiomyocytes
Given that Mdk is actively taken into the cells, we examined
whether it then affects the cell viability of the human
CMs. The cell viability of the human CMs was neither
affected by different Mdk concentrations nor by different
incubation times (Figures 2B,C). Furthermore, there were no
differences in troponin I concentrations in supernatant of
the humans CMs treated with Mdk compared to control
cells after 6 h (Figure 2D). However, the calcium handling
of the human CMs was altered after Mdk treatment, which
is exemplified by the significant increase in their delta
calcium peaks (Figure 3A), meaning the cells beat slower in
presence of Mdk. Moreover, the frequency of calcium signals
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in human CMs decreased significantly in presence of Mdk,
developing bradycardic conditions (Figure 3B), which is also
demonstrated the traces of the calcium signals of the cells
(Figures 3C–F).
Gene Expression of Human
Cardiomyocytes
We showed that Mdk alters the calcium handling in human
CMs. Next, we investigated the gene expression of specific cardiac
calcium pumps as well as the expression of different receptors,
which might be involved in Mdk signaling. In human CMs, the
mRNA expression of SERCA2a, NCX, TLR4, TLR9, and P2X7
increased significantly in presence of Mdk compared to control
(Figures 4A,C–F), indicating for direct effects of Mdk on gene
expression of calcium handling proteins. Moreover, the effects
of Mdk might be mediated via TLR-P2X7 signaling. The mRNA
expression of RyR1 was unaffected (Figure 4B).
Mitochondrial Respiration of Human
Cardiomyocytes
In addition, we analyzed the effects of Mdk on the mitochondrial
respiration of CMs Figure 5A. The basal respiration as well
as the spare respiratory capacity of the human CMs decreased
significantly after the Mdk treatment (Figures 5B,C), indicating
detrimental effects of Mdk on mitochondrial respiration.
Intracellular Reactive Oxygen Species
(ROS) and Caspase3/7 Activity
As Mdk alters mitochondrial respiration and ATP production
of the cells, we next investigated whether Mdk also affects the
redox balance of the human CMs. The amount of ROS did not
change in human CMs after being treated with Mdk compared to
control cells (Figure 5D). Although Caspase3/7 activity increased
significantly in human CMs in presence of Mdk (Figure 5E),
indicating for enhanced apoptosis in the cells.
Filtration of Midkine by CytoSorb® 300
Because Mdk is elevated in plasma of multiply injured humans
and pigs and acts on human CMs, we examined the potential
of a therapeutic approach: the absorption capacity of Mdk from
human blood by CytoSorb R© 300. After incubation of different
Mdk concentrations with CytoSorb R© 300, the Mdk levels
decreased between 45 and 95% within 6 h (Figure 6A). Especially
high Mdk concentrations (10,000 pg/ml) were significantly
reduced up to 95% after filtration with CytoSorb R© 300 after
6 h compared to the 3 h incubation (Figure 6A). Moreover,
Mdk levels in plasma from multiply injured patients were
significantly reduced after incubation with CytoSorb R© 300
(Figure 6B).
DISCUSSION
Our study shows for the first time that Mdk is elevated in
blood circulation after multiple trauma. This elevation is similar
to other traumatic injuries, suggesting that circulating Mdk
may act as a novel inflammatory marker for polytrauma (8, 9,
11). Furthermore, we demonstrated that Mdk acts directly on
FIGURE 4 | Gene expression of human cardiomyocytes treated for 6 h with
100 ng/ml Midkine. mRNA expression (in fold change) of sarco/endoplasmatic
reticulum Ca2+-ATPase (SERCA2a) (A), ryanodine receptor-1 (RyR1) (B),
sodium-calcium exchanger (NCX) (C), purigenic P2X receptor subtype 7
(P2X7) (D), toll-like receptor 4 (TLR4) (E), toll-like receptor 9 (TLR9) (F). Results
are presented as mean ± SEM. Data were analyzed by two-tailed, unpaired
students t-test. For all experiments n = 6. Results are significant *p < 0.05.
human cardiomyocytes in vitro and is actively taken up by these
cells, altering their functionality without affecting their viability.
We found that Mdk affects the functionality of the human
CMs by altering their calcium handling. The delta calcium
peaks of the human CMs increased significantly after Mdk
treatment, meaning the cells became bradycardic. Moreover,
the frequency of the calcium signals in human CMs decreased
significantly after Mdk treatment, confirming the bradycardic
effect of Mdk. The mRNA expression of the specific cardiac
calcium pumps SERCA2a and NCX also increased significantly
after Mdk treatment, suggesting direct effects of Mdk on calcium
handling in the cells. The location of Mdk around the cell nucleus
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FIGURE 5 | Mitochondrial respiration, cellular reactive oxygen species (ROS) and Caspase 3/7 activity of human cardiomyocytes treated for 6 h with 100 ng/ml
Midkine. Oxygen consumption rate (OCR) of human cardiomyocytes (Control, Midkine) during Seahorse MitoStress Assay (OCR in pmol/min/E630 vs. time in min) (A).
Basal respiration of human cardiomyocytes (OCR in pmol/min/E630) (B). Spare respiratory capacity of human cardiomyocytes (OCR in pmol/min/E630) (C). Amount
of reactive oxygen species (mean fluorescence intensity, MFI) (D). Caspase 3/7 activity (Luminescence in counts/sec) (E). Results are presented as mean ± SEM. For
all experiments n = 6. Data were analyzed by two-tailed, unpaired students t-test. Results are significant *p < 0.05.
of the human CMs confirmed the regulatory effects on cellular
gene expression of the calcium handling proteins. Alterations
in calcium signals as well as in mRNA expression of SERCA2a
and NCX were also described previously in presence of other
trauma-related inflammatory biomarkers and DAMPs as well
as in different trauma models and during sepsis, nominating
Mdk as a powerful cardio-depressive mediator after trauma
and during sepsis (25, 37–42). However, cardiac overexpression
of SERCA2a in rodents improved cardiac contractility and
relaxation, which might also indicate potential protective effects
of Mdk in the heart, which would require to be investigated
in future studies (43, 44). We also novelly showed that the
basal respiration as well as the spare respiratory capacity of
the mitochondria of the human CMs decreased significantly,
indicating detrimental effects of Mdk on cellular mitochondrial
respiration and energy production. Nevertheless, the amount of
cytosolic reactive oxygen species (ROS) was not altered in the
human CMs in presence of Mdk. Mitochondrial dysfunction
was also depicted previously for other trauma-related biomarkers
(7, 45, 46). The detrimental and cardio-depressive effects of Mdk
on the human CMs might be mediated via the toll-like receptor
(TLR) 4, TLR9, and the pyrogenic receptor subtype 7 (P2X7)
since the mRNA expression of these receptors was significantly
upregulated. All of these receptors have been demonstrated to
be involved in the DAMP-associated cardiac signaling pathways
in different trauma models (47, 48). The activation of the TLRs
results in increased cardiac inflammation, mediated via the
nuclear factor κ B (NFκB) (47). This TLR-mediated cardiac
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FIGURE 6 | Filtration of Midkine by CytoSorb® 300. Filtration of different
Midkine concentrations (10,000, 5,000, 2,500, 2,000, 1,500, 1,000 pg/ml) (n
= 6) with CytoSorb® 300 after 3 h (black bars) and 6 h (white bars) (A).
Midkine concentration before and after filtration with CytoSorb® 300 on the
x-axis in pg/ml. Midkine levels (pg/ml) in human shock room blood plasma of
multiply injured patients before and after filtration with CytoSorb® 300 (n = 11)
(B). Results are presented as mean ± SEM. Data were analyzed by one-way
ANOVA followed by Dunnett’s or Tukey’s multiple comparison test. Results are
significant *p < 0.05.
inflammation leads to cardiac injury and finally results in cardiac
contractile dysfunction (47–49). Since the mRNA expression
of the TLRs was upregulated, the protein expression of these
receptors might be increased after Mdk treatment. This might
lead to sensitization of the CMs for other systemic circulating
DAMPs, such as HMGB1 and extracellular histones, which were
elevated after polytrauma, leading to cardiomyocyte dysfunction
(7, 24, 50). The P2X7 receptor was also shown to be involved
in cardiac contractile dysfunction (51). Interestingly, the Caspase
3/7 activity increased in human CMs after treatment with Mdk,
which was demonstrated previously in cardiac tissue in vivo in
an experimental polytrauma model in pigs (41). So far, Mdk
was described as an anti-apoptotic factor by decreasing caspase
activity in other cells, such as neurons and HepG2 cells, which
is in accordance to unaffected cell viability in the present study
(52, 53). The effects of Mdk on cellular apoptosis of human CMs
has not been described, so far. In contrast to other cells, human
CMs seem to follow different cellular processes and various
signal cascades might be involved in Caspase-3/7 activation
and activity when these cells were treated with Mdk. Moreover,
this phenomenon could also be time-dependent as we solely
investigated the Caspase-3/7 activity after 6 h of Mdk exposure.
This observation should be the subject of future studies in
FIGURE 7 | Schematic representation of systemic inflammation after trauma
and during sepsis. After trauma Midkine is released systemically. Midkine
recruits polymorphonuclear neutrophils (PMNs) and induces the release of
extracellular traps (NETosis) via the receptor-related protein 1 (LRP1) on the
neutrophils, which was demonstrated by Weckbach et al. (23), (1). The
neutrophil extracellular traps (NETs) include extracellular histones, which act via
toll-like receptors (TLRs) on the surface of cardiomyocytes, inducing cardiac
dysfunction and cardiac damage. Furthermore, Midkine is able to act
detrimental on human cardiomyocytes by direct interactions via TLR4, TLR9,
and pyrogenic receptor subtype 7 (P2X7), inducing enhanced apoptosis,
disturbing calcium signaling and impairing mitochondrial respiration (2,
Hypothesis of this manuscript). Additionally, after trauma and during sepsis the
complement factors C5a and C3a are released systemically. Both act directly
via their receptors (C5aR, C3aR) on cardiomyocytes, leading to cardiac
dysfunction. Moreover, the complement factors also induce NETosis of
neutrophils via their receptors.
order to understand the specific effects of Mdk on apoptosis of
human CMs.
Therapeutic approaches treating post-traumatic cardiac
dysfunction are still limited. In this study, we clearly showed
that Mdk is elevated in plasma after multiple trauma and
is predominantly detrimental on human CMs, causing the
development of post-traumatic cardiac dysfunction. As a
consequence, we investigated the efficiency of CytoSorb R© 300 in
filtering Mdk from human blood plasma. CytoSorb R© 300 is an
absorption column, composed of porous polymer beads, which is
normally used in the intensive care unit (ICU) for septic patients
or for patients with SIRS. The filtration potential of CytoSorb R©
300 for various trauma-associated cytokines and DAMPs was
already demonstrated by others (31, 54). Here, we showed
for the first time that CytoSorb R© 300 is able to absorb Mdk
dose-dependently, filtering high Mdk concentrations (10,000
pg/ml) up to 95%. Moreover, CytoSorb R© 300 filtered Mdk
from human plasma obtained on admission to the emergency
room, making it a very promising therapeutic approach for
treatment and prevention of post-traumatic cardiac dysfunction.
One huge benefit of using CytoSorb R© 300 instead of single
antibodies for therapy is that CytoSorb R© 300 is able to filter a
high amount of many miscellaneous damage- and inflammation
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molecules after trauma and not only a single molecule, which
is the case of antibody treatment. Furthermore, filtration of
Mdk by CytoSorb R© 300 might limit other negative effects of
Mdk on polytrauma patients, since it was shown that Mdk acts
as an inhibitor of fracture healing and that high Mdk serum
levels were associated with poor outcome in septic patients.
Finally, we found that systemic Mdk is higher after conventional
reaming, compared to nailing without reaming and to RIA I/II.
Consequently, treatment of the fracture with RIA I/II might
be better for fracture outcome as well as for fracture healing
after trauma (55). In addition, conventional reaming of the
fracture might have other negative effects after trauma (e.g.,
pulmonary embolism).
One limitation of the study might be the small sample size
(n = 6) to investigate different treatment approaches for the
femur fracture. Consequently, more experiments are needed to
find the best and the least invasive treatment approach. The
same applies for a possible correlation between fracture treatment
approaches and systemicMdk levels. Because investigated groups
were heterogenous, a bigger number of samples might be helpful
to extrapolate the results to a clinical population. Another
limitation might be that we only used small columns with
Cytosorb R© 300 polymer beads in our study, trying to mimic
the clinical application in ICU. However, as our study was only
an experimental approach, clinical studies should be performed,
including more patients and larger application approaches of
Cytosorb R© 300. This may help to- confirm the therapeutic
potential of Cytosorb R© 300 for the prevention of post-traumatic
cardiac dysfunction by filtering Mdk from human blood in
vivo. Furthermore, it is not possible to mimic in vitro the real
in vivo inflammatory conditions, which occur after trauma.
The presence of many different inflammatory mediators and
DAMPs and the activation of different signal cascades in the cells
lead to post-traumatic cardiac dysfunction. Consequently, it is
not possible to specify these detrimental effects on one single
mediator like Mdk.
Taken together, in our study we observed for the first
time that Mdk is elevated systemically after multiple trauma
in humans and pigs, acting cardio-depressive on human
CMs by impairing their calcium handling and mitochondrial
respiration capacity in vitro. PlX27/TLR might be involved
in mediating these detrimental effects of MdK (Figure 7). In
the clinical setting, the hemadsorption filter Cytosorb R© 300
might be a powerful tool to remove cardio-depressive mediators
from patients’ circulation and therefore help to improve
cardiac function.
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